OmniAb, Inc. (OABI) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

20/25

Growth 4 Margin 4 Expansion 4 Platform 5 Financial 3

latest quarter score

Earnings Reports

20
OmniAb (OABI) Q2 2026: Milestone Revenue Jumps 244% as Clinical Pipeline Advances
August 07, 2026
14
OmniAb (OABI) Q1 2026: Milestone Revenue Surges 243% on Pipeline Progress, Guidance Raised
May 08, 2026
16
OmniAb (OABI) Q4 2025: Active Programs Up 12%, Innovation Engines Expand Addressable Market
March 05, 2026
14
OmniAb (OABI) Q3 2025: Program Count Hits 399, OmniUltra Launch Expands Peptide Market Access
November 05, 2025
16
OmniAb (OABI) Q2 2025: Exploration Launch Drives 22% Growth in Post-Discovery Pipeline
August 06, 2025
23
OmniAb (OABI) Q1 2025: Exploration Launch Expands Revenue Streams as Post-Discovery Assets Rise 39%
July 05, 2025
18
OmniAb (OABI) Q4 2024: 18% Growth in Active Partners Highlights Expanding Platform Reach
March 18, 2025

Browse all companies